2023
DOI: 10.1016/j.ejps.2023.106471
|View full text |Cite
|
Sign up to set email alerts
|

Paediatric solid oral dosage forms for combination products: Improving in vitro swallowability of minitablets using binary mixtures with pellets

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 55 publications
0
2
0
Order By: Relevance
“…Future drug product development is likely to customize existing approaches and make use of a contemporary SODF, such as pellets and minitablets, 64 to improve acceptability and thus adherence for all individuals, while also addressing the specific needs of particular patient populations, such as pediatrics, older adults, those with dysphagia, and those with cognitive impairment. 6 To deliver a truly patient-centered approach to drug product design, patients need to be more actively involved in designing drug products so as to directly determine their priorities and what is important to them.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Future drug product development is likely to customize existing approaches and make use of a contemporary SODF, such as pellets and minitablets, 64 to improve acceptability and thus adherence for all individuals, while also addressing the specific needs of particular patient populations, such as pediatrics, older adults, those with dysphagia, and those with cognitive impairment. 6 To deliver a truly patient-centered approach to drug product design, patients need to be more actively involved in designing drug products so as to directly determine their priorities and what is important to them.…”
Section: Discussionmentioning
confidence: 99%
“…The EMA recently published a letter of support 63 for testing oral drug product acceptability in children <12 years using the ClinSearch Acceptability Score Test ® , which was developed following publication of the EMA guideline on pharmaceutical development of drug products for pediatric use. 11 Future drug product development is likely to customize existing approaches and make use of a contemporary SODF, such as pellets and minitablets, 64 to improve acceptability and thus adherence for all individuals, while also addressing the specific needs of particular patient populations, such as pediatrics, older adults, those with dysphagia, and those with cognitive impairment. 6 To deliver a truly patient-centered approach to drug product design, patients need to be more actively involved in designing drug products so as to directly determine their priorities and what is important to them.…”
Section: Discussionmentioning
confidence: 99%